Sofia Falkner’s practice focuses on Swedish- and EU antitrust and competition law where she advises clients in e.g., cartel investigations, dominance issues, cross-border and domestic merger control and distribution arrangements. She has a particular experience in managing internal and external competition/antitrust investigations.
Furthermore, Sofia advises clients in all aspects of public procurement, from drafting of tenders to appeal of award decisions. She also has experience of regulatory and compliance issues within the pharmaceutical- and medtech sectors.
Sofia is recommended and has been ranked as a ‘Rising Star’ by Legal 500 for three consecutive years.
"Sofia Falkner is a rising star. Very competent, accurate and clever. Even though she is not yet a partner you can always be safe relying on her advice, even on complex matters."
Areas of expertise
Employment with other law firm
Member of the Swedish Bar Association
"Sofia Falkner is very competent and clever. She has learnt our business very fast and is able to give us relevant and good assistance with all questions. Her recommendations are always clear and easy to apply" Legal 500, 2020
Örebro University (juris kandidat, LL.M.)
Co-author of “The Legal 500: Cartels Country Comparative Guide", 2021
Co-author of “ICC Compendium of Antitrust Damages Actions”, 2021
Co-author of “Lexology – Getting the Deal Through on "Pharma & Medical Device Regulation – Sweden”, 2020
Co-author of “The Legal 500 (Legalease): Merger Control Country Comparative Guide ”, 2020
Co-author of "The Legal 500 & The In-House Lawyer Comparative Guide to Cartels", 2019
Co-author of “Lexology - A structured guide to the Cartel Regime in Sweden", 2019
Co-author of "Lexology – Getting the Deal Through on "Life Sciences: Product Regulation and Liability in Sweden", 2019
Co-author of “Lexology – Getting the Deal Through on "Pharmacovigilance in Sweden", 2019
Co-author of “Lexology – Getting the Deal Through on "Life Sciences: Compliance and enforcement in Sweden", 2019
Co-author of “Lexology – Getting the Deal Through on "Clinical trials in Sweden", 2019